Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000809824 | SCV000950003 | uncertain significance | Multiple endocrine neoplasia type 4 | 2018-11-15 | criteria provided, single submitter | clinical testing | This sequence change disrupts the translational stop signal of the CDKN1B mRNA. It is expected to extend the length of the CDKN1B protein by 1 additional amino acid residues. This variant is not present in population databases (ExAC no frequency). This variant has not been reported in the literature in individuals with CDKN1B-related disease. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Experimental studies and prediction algorithms are not available for this variant, and the functional significance of the affected amino acid(s) is currently unknown. |